Background
==========

Sheehan's syndrome was first described by the British pathologist Harold Leeming Sheehan in 1937 as postpartum pituitary necrosis, most often caused by significant postpartum hemorrhage though as in our case not always a major bleeding is described. Sheehan's syndrome is a relatively rare condition in developed countries compared to developing countries and is therefore not infrequently overlooked, especially in the absence of a major post-partum hemorrhage ([@bib1], [@bib2]). The syndrome may present with an inability to lactate postpartum, but not infrequently, it may be diagnosed years after the inciting delivery with variable pituitary hormonal deficiencies ([@bib1], [@bib3]). Many nonspecific manifestations are possible depending on individual's hormonal losses which may vary, though failure to lactate and amenorrhea are relatively common ([@bib1], [@bib2]). Acute hyponatremia as the main presenting problem is less common. It has been described in few case reports following a significant postpartum hemorrhage and the development of a hemorrhagic shock ([Table 1](#tbl1){ref-type="table"}). The main differential diagnosis is between lymphocytic hypophysitis and Sheehan's syndrome ([@bib4]). There is a significant clinical overlap between the two conditions while MRI images of the pituitary may be very helpful in differentiating between the two conditions ([@bib1]). Table 1Comparison of Sheehan's syndrome case reports resulting in acute hyponatremia.First authorBlood loss (L)Shock (yes/no)Clinical manifestationPutterman ([@bib10])2YesParesthesiaBoulanger ([@bib11])Not describedNot describedAstheniaSchrager ([@bib12])Not described (severe)YesFatigueLust ([@bib13])3.2YesHeadacheBunch ([@bib14])MassiveYesHeadacheKaplun J ([@bib15])MassiveYesHeadache, feverAnfuso ([@bib16])0.5NoAsthenia, headacheMatsuzaki ([@bib17])5YesConvulsion, comaCurrent case1NoFever, headache, fatigue

Case presentation
=================

A healthy 24-year-old female G2P2, 39-week pregnant with a normal pregnancy follow-up, presented to the obstetric emergency department due to uterine contractions. Labor induction was performed due to lack of progress of labor. Fetal heart rate monitoring showed a non-reassuring fetal heart rate (NRFHR) and the patient underwent an emergent caesarean section without major bleeding (1000 mL). The pre-operative hemoglobin levels were 7.8 g/dL and the post-operative level was 7.2 g/dL. On the second POD, the patient complained of severe headache, fatigue and failure to lactate. Brain CT scan demonstrated an abnormal unspecific supra-sellar mass. On POD5 the patient had fever of 39 for the first time during the admission. Empiric antibiotic therapy was initiated with a working diagnosis of endometritis due to nonspecific abdominal complaints and after chest X-ray and urinalysis were within normal range. Abdominal CT scan ruled out an abdominal abscess and other source of infection. Blood and urine cultures were negative. Simultaneously a routine biochemical investigation revealed new-onset hyponatremia (Na = 124 mEq/L, POD2 level was 148 mEq/L, [Table 2](#tbl2){ref-type="table"}) (normal range 135--145). Urine analysis showed osmolarity of 572 mosmol/kg and a urine sodium of 149 mEq/L consistent with the syndrome of inappropriate ADH (SIADH). She was treated accordingly with fluid restriction, furosemide, salt tablets and eventually hypertonic saline. Sodium levels failed to rise, and the patient was transferred to the internal medicine ward. Physical examination upon admission was prominent for weakness, lethargy and altered mental status. Blood pressure measurements were at the low end of normal range (90/50 mmHg). Table 2Patient's relevant blood tests during pregnancy and presentation.ParametersPregnancy age8 weeks25 weeks39 weeks (POD2)POD11Hb (g/dL)139.47.87.5Na (mEq/L)138--148117K (mEq/L)4--4.15.1TSH (uIU/mL)2.492.1--0.12Free T3 (pg/mL)------1.8Free T4 (pg/mL)------0.6

Investigation
=============

Thyroid function tests were obtained and were consistent with central hypothyroidism. A complete hormonal workup demonstrated anterior hypopituitarism ([Table 3](#tbl3){ref-type="table"}); the possibility of Sheehan's syndrome and lymphocytic hypophysitis were considered and a brain MRI was ordered in order to differentiate between the two. On POD17 the patient performed a brain MRI ([Figs 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}) which showed a normal, non-thickened central pituitary stalk, a normal pituitary with circumferential enhancement following gadolinium injection consistent with Sheehan's syndrome. Several days following discharge the patient developed polyuria and nocturia, dehydration test was performed and was consistent with partial central DI with good response to DDAVP.Figure 1Patients' brain MRI. Figure 2Patients' brain MRI. Table 3Blood hormone levels on POD5.HormonesValuesTSH0.12 uU/L (0.39--4)FT31.8 pg/dL (2.3--4.2)FT40.6 pg/dL (0.8--1.5)Cortisol (08:00 AM)\<0.6 ug/dLCortisol after ACTH stimulation administration5.26 ug/dLProlactin7 ng/mL (1--29)\*LH\<0.2 IU/L^¶^FSH0.4 IU/L^¶^Estradiol\<21 pg/mL^¶^Growth hormone\<0.05 ng/mL (0--5)IGF-175 µg/L (102--317)[^1][^2]

Treatment
=========

As soon as there were findings consistent with adrenal insufficiency, the patient was initially treated with IV hydrocortisone followed by thyroid hormone replacement which resulted in a rapid clinical and biochemical response, including reversal of hyponatremia. Until the completion of brain MRI, no additional treatment was given as there was doubt whether the diagnosis was Sheehan's syndrome or lymphocytic hypophysitis. On follow-up visits in the endocrine unit clinic, DDAVP, estrogen-based hormone replacement therapy and growth hormone treatment were added.

Outcome and follow-up
=====================

As described earlier, glucocorticoids and thyroid replacement therapies resulted in a rapid laboratory and clinical improvement. DDAVP treatment resulted in a good clinical response with a decrease in polyuria and nocturia. The patient is currently at our hospital's endocrinology clinic follow-up. Ten months after the inciting delivery, the patient feels well with no specific complaint. The patient will require a lifelong hormonal replacement therapy.

Discussion
==========

The diagnosis of Sheehan's syndrome is frequently overlooked and is not infrequently made only years after the inciting delivery suggesting underdiagnosis in general, and specifically during the peri-partum period ([@bib3], [@bib5]). A higher index of suspicion should rise when dealing with a women from a third-world country or following a history of a home delivery where rates of peri-partum bleeding are more common ([@bib1], [@bib2]). However, rarely as in the current case, Sheehan's syndrome may develop without any obvious post-partum bleeding and in a developed country with modern medical care. The main differential diagnosis of Sheehan's syndrome is lymphocytic hypophysitis and both may present in the peripartum period with headache and pituitary hormonal deficiencies. The differentiation between the two conditions is primarily based on the lack or presence of a major PPH, distinctive brain MRI findings, higher rates of posterior pituitary failure and a concurrent autoimmune disease in lymphocytic hypophysitis ([@bib1], [@bib6]). In the current case, despite the lack of a major PPH, the diagnosis of Sheehan's syndrome was made mainly due to suggestive brain MRI findings and the lack of the typical MRI findings of hypophysitis. In addition, the lack of an additional autoimmune process supported Sheehan's syndrome, while partial central DI was diagnosed later in our patient and is not typical of Sheehan's syndrome. Nevertheless, we decided not to treat with pharmacological doses of corticosteroids, in addition to treatment of the hormonal deficiencies. Sheehan's syndrome may lead to serum sodium level abnormalities. Hypernatremia may develop in the setting of posterior pituitary necrosis and central diabetes insipidus ([@bib7]). Hyponatremia is a more common manifestation and occurs when adrenal insufficiency or hypothyroidism develop as they are both etiologies for euvolemic hyponatremia ([@bib8]). Hyponatremia, and specifically euvolemic hyponatremia is a condition of many etiologies and all must be taken into consideration as a part of the hyponatremia workup ([@bib9]). When approaching a clinical condition, whatever it may be, one must always remember that common findings may be caused by rare conditions and consider an alternative diagnosis upon treatment failure.
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[^1]: \*Normal range to a non-pregnant non-lactating female; ^¶^all measurements are below minimal values regardless to the timing during the menstrual period.

[^2]: FSH, follicular-stimulating hormone; IGF-1, insulin-like growth factor 1; LH, luteinizing hormone; TSH, thyroid-stimulating hormone.
